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Abstract: Early diagnosis of renal damage in Leishmania infected dogs may allow appropriate
treatments and prevent some deaths. This study investigates neutrophil gelatinase-associated lipocalin
(NGAL) as a biomarker of kidney disease in dogs experimentally infected with Leishmania infantum.
Serum, urine, and kidney samples were collected from 30 infected beagle dogs and six uninfected
control dogs. Based on proteinuria and azotemia values, dogs were initially classified. NGAL was
measured in urine and serum samples. Then, the urinary NGAL to creatinine ratio (uNGAL/C)
was calculated. Kidney samples were taken for histopathological studies, and the dogs were
classified according to the severity of glomerular and tubulointerstitial lesions. In Leishmania-infected
dogs, the uNGAL/C was significantly higher in proteinuric non-azotemic dogs compared with
non-proteinuric non-azotemic dogs (p = 0.038). Serum NGAL (sNGAL) concentration did not differ
between groups. Microscopic studies revealed several degrees of glomerulonephritis and slight focal
lymphoplasmacytic interstitial nephritis in 89% and 55% of infected dogs, respectively. Urinary
protein to creatinine ratio (UPC) and uNGAL/C were significantly higher in dogs with affected
glomeruli compared to infected dogs without renal lesions (p = 0.045 and p = 0.043, respectively).
The results show that uNGAL/C correlates with proteinuria and the presence of moderate glomerular
lesions in non-azotemic dogs experimentally infected with L. infantum.
Keywords: canine leishmaniasis; NGAL; kidney disease; proteinuria; glomerular lesions
1. Introduction
Canine visceral leishmaniasis is caused by the protozoan Leishmania infantum, which affects several
organs, for example, the skin, kidneys, spleen, liver, and eyes, and is characterized by a range of
associated clinical signs [1]. Renal lesions are characterized by glomerular and interstitial lesions,
typically associated with immune complex deposition [2]. Consequently, Leishmania-infected dogs may
develop acute kidney injury (AKI) or, more frequently, chronic kidney disease (CKD) [3,4]. Diagnosing
and treating kidney injury in its early stages is crucial for minimizing and potentially avoiding chronic
and fatal progression of kidney disease [1].
Current protocols for the treatment of canine leishmaniasis are mainly based on the renal status,
which is estimated following the International Renal Interest Society guidelines (IRIS Group) [5,6].
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They recommend measuring serum creatinine (sCr) concentration and the UPC for diagnosing, staging,
and treating both AKI and CKD. The UPC quantitatively measures proteinuria and is routinely used
in canine leishmaniasis diagnosis, due to its increase being one of the first abnormalities occurring
in renal impairment [6,7]. However, sCr, a kidney function marker, is insensitive for diagnosing
an early renal injury, before functional impairment occurs, and it is only detected when at least
75% of nephrons are non-functional [8]. Although histopathology is the best method to assess
early renal damage for studying proteinuric kidney diseases [9], a kidney biopsy is an invasive
technique and not routinely performed. Ultrastructural studies are typically required for an adequate
evaluation of renal damage, but light microscopy is more often performed for studying proteinuric
kidney diseases, mainly due to cost and technical reasons [9]. Consequently, recent studies assert the
necessity of more sensitive biomarkers of early damage in canine renal diseases [10], and alternative
urinary biomarkers of renal damage are increasingly studied. A number of these biomarkers can
localize the site of the renal injury. For example, immunoglobulin G (IgG) [11], C-reactive protein
(CRP) [12], and ferritin [13] concentrations in urine are associated with glomerular lesions, whereas
N-acetyl-β-d-glucosaminidase (NAG) [14] or gamma glutamyl-transpeptidase (GGT) [15,16] levels
reflect tubular lesions. These biomarkers have been compared with traditional tests; however, they
have been infrequently correlated with histopathological lesions in kidneys [16,17].
Neutrophil gelatinase-associated lipocalin (NGAL) is a glycoprotein with a molecular weight
of 25 kDa and a member of the lipocalin family. It was initially purified from neutrophils during
infection and inflammation [18]. However, NGAL is also expressed in the uterus, prostate gland,
salivary glands, bone marrow, stomach, colon, trachea, lungs, liver, and kidneys [19]. NGAL is
considered a good biomarker for both the early diagnosis of renal injury and the evaluation of its
progression [20]. Moreover, it has been shown to predict adverse outcomes of CKD, such as end-stage
renal disease [21–23]. Additionally, NGAL has been associated with several conditions in humans,
including immunological [24], metabolic (i.e., diabetes) [25], and inflammatory (i.e., acute generalized
peritonitis) [26] diseases.
It is one of the most studied biomarkers in veterinary medicine [27] and may be a good early
biomarker of both acute and chronic kidney injury [9,27–29]. In dogs, increasing evidence shows that
urinary NGAL (uNGAL) correlates with the degree of renal damage [10]. It seems to be a sensitive and
specific marker of AKI, although it remains to be determined whether NGAL is an early predictor of
CKD [30]. However, it has not been studied in dogs with leishmaniasis.
As kidney disease is frequent in Leishmania-infected dogs and may lead to end-stage renal
failure [31], the aim of the study was to investigate uNGAL values in dogs experimentally infected
with L. infantum and compare them with the renal parameters routinely used (sCr and UPC values)
and with the microscopic findings observed in the kidney. This work shows that uNGAL increases
in proteinuric dogs without azotemia, and that correlates with the presence of glomerular lesions
observed by histopathology in dogs experimentally infected with L. infantum.
2. Materials and Methods
2.1. Animals, Samples, and Ethical Statements
Thirty (15 females and 15 males) intact, healthy, eight-month-old, ~13 kg beagle dogs were
experimentally infected intravenously with one mL of an inoculum that had a concentration of
1 × 108 promastigotes/mL of L. infantum (isolate MCAN/ES/Z002) obtained as previously described [32].
The isolate corresponded with genotype A (Maribel Jiménez and Ricardo Molina, personal communication)
according to ITS-based genotyping [33]. Additionally, six beagles (three females and three males) were
kept as uninfected controls. All these dogs were a subsample from a larger experiment in which all
animals were periodically examined to determine their health status: ~180 days post-infection (dpi),
~240 dpi, ~300 dpi, and ~360 dpi. Special consideration was given to clinical renal status, and no
medical treatments that could affect kidneys were administered to any dog throughout the experiment.
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All animals received regular exercise and social interaction and were housed, maintained, and used for
experimentation at optimal conditions: Ad-libitum feeding, procedure refinement, disease monitoring,
behavioral enrichment, and temperature control.
At the end of the study, ~360 dpi, animals were euthanized following sedation, by using 0.3 mL/kg
of T61 (Intervet) by the intravenous route. Afterward, a complete necropsy was performed. Prior to
euthanasia, blood and urine samples were taken. Blood samples were obtained by cephalic vein
puncture and urine samples by guided ultrasound cystocentesis.
One mL of urine was used to perform a complete urinalysis and evaluation of the sediment.
Pyuria was considered when more than 10 leukocytes/µL or more than six altered leukocytes per
high-power field (400×) were observed. No abnormal results were found. The remaining urine
was centrifuged at 300× g for two minutes and kept at −80 ◦C for one month until NGAL analysis.
Blood samples were centrifuged at 1200× g for ten minutes to obtain the serum and kept at −20 ◦C
for further studies. One dog was not sampled because had to be euthanized before the end of the
experiment (after the ~240 dpi time point). The animal reached the animal welfare endpoints set before
the study.
All applicable international, national, and/or institutional guidelines for the care and use of animals
were followed (Spanish Policy for Animal Protection RD53/2013, which meets the European Union
Directive 2010/63 on the protection of animals used for experimental and other scientific purposes).
All efforts were made to minimize suffering. All experimental practices involving animals were
approved by the Ethics Committee for Animal Experiments from the University of Zaragoza (Project
license PI28/14, date of approval: 4 June 2014).
2.2. Clinical Signs and Serological Study
Clinical signs evaluation and serological determinations to confirm the infection was carried out
every two months from 180 dpi. Until the end of the experiment (~180 dpi, ~240 dpi, ~300 dpi, and
~360 dpi). Clinical signs characteristics of leishmaniosis were specially assessed: Weight loss, peripheral
lymphadenomegaly, skin lesions (desquamative dermatitis, alopecia, and ulcers), temporal muscle
atrophy, splenomegaly, polyuria/polydipsia, epistaxis, ocular lesions, onychogryphosis, lameness, and
vomiting/diarrhea. Dogs without signs were considered asymptomatic, dogs with less than three
signs were considered oligosymptomatic, and dogs with three or more clinical signs were classified
as polysymptomatic. Additionally, clinical signs related with urinary tract infections (UTI), such as
stranguria, pollakiuria or dysuria, were also assessed.
Leishmania serology was done using two techniques. A commercial ELISA kit with a sensitivity of
92.5% and a specificity of 100% [34] (CIVTEST CANIS LEISHMANIA 192, Hipra Laboratories S.A.
Gerona, Spain). The technique was performed according to the manufacturer’s instructions and the
sera were considered negative (Rz < 0.9), doubtful (0.9 < Rz < 1.1), low positive (1.1 < Rz < 1.5) and
positive (Rz > 1.5). On the other hand, a direct agglutination test (DAT) was used as previously
reported [35], with a sensitivity of 100% and a specificity of 98.7%. Negative results were considered
when DAT dilution was <1/200, doubtful when dilution was 1/400, low positive when dilution was
1/800, and positive when dilution was >1/800.
2.3. Biochemical and Hematological Analyses
At ~180 dpi, ~240 dpi, ~300 dpi, and ~360 dpi, biochemical and hematological analyses were
carried out. Biochemical determinations were performed for albumin (ALB), alkaline phosphatase
(ALP), Urea, Creatinine (sCr), aspartate aminotransferase (AST), alanine aminotransferase (ALT),
lactate dehydrogenase (LDH), total bilirubin (T-Bil) and total protein (T-Pro) with the Automatic
Analyser Gernon Star (RAL, Barcelona, Spain). Routine hematological analyses were also performed
to assess anemia, leukopenia, and thrombocytopenia with the hematological equipment XT-SYSMEX
2000 iV (Roche Diagnostics, Barcelona, Spain).
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2.4. Proteinuria and Azotemia Determinations and Group Allocation
To assess proteinuria, during the last month, three urine samples were collected every 15 days.
The UPC was calculated to estimate the degree of proteinuria. Urinary total proteins were measured
by the pyrogallol red-molybdate method. Creatinine levels in serum and urine were measured by the
creatinase and sarcosine enzymatic method (Automatic Analyser Gernon Star, RAL, Barcelona, Spain).
Dogs were classified according to UPC and sCr values based on the guidelines of the IRIS
Group [36]. Depending on UPC values, dogs were considered as non-proteinuric (UPC < 0.2),
borderline proteinuric (UPC between 0.2–0.5) and proteinuric (UPC > 0.5). Azotemia was defined as
sCr > 1.4 mg/dL.
To assess if NGAL was sensitive enough to detect renal disease, dogs were classified into four
groups using both sCr and UPC: Group 1, non-proteinuric and non-azotemic dogs; Group 2, borderline
proteinuric and non-azotemic dogs; Group 3, proteinuric and non-azotemic dogs; Group 4, proteinuric
and azotemic dogs [13].
2.5. Serum NGAL, Urinary NGAL, and uNGAL/C Determinations
As NGAL can also increase with inflammatory conditions [24], and inflammation is typically
observed in Leishmania-infected dogs, NGAL was also determined in serum to discard an inflammatory
origin. Furthermore, it has been suggested that uNGAL and sNGAL should be evaluated together
to minimize any influence from other systemic diseases [37]. Serum and urine samples collected at
~360 dpi were thawed to realize the NGAL determinations. Serum and urine NGAL concentrations
were measured with a commercial ELISA kit validated in dogs (Dog NGAL ELISA Kit, Bioporto
Diagnostics A/S, Gentofte, Denmark) following the manufacturer´s instructions. The absorbance
was measured with an ELISA reader (Tecan Sunrise Microplate Reader, Switzerland) at 450 nm.
For statistical analysis, values below the detection limit (4 pg/mL) were assigned a value of 2 pg/mL [38].
The urinary concentration of NGAL may be influenced by hydration status or urinary concentration
capacity. Accordingly, the uNGAL/C was used to control for individual variations, as it adjusts for
heterogeneity in urinary concentration [38]. For urine samples, intra- and inter-assay coefficients of
variations (CV) were below 2% and 9%, respectively, and for plasma samples, they were below 3% and
8%, respectively. Then, sNGAL and uNGAL concentrations were expressed as mg/dL.
2.6. Histopathological Study and Group Allocation
To assess the condition of the nephrons and the origin of the damage, a histopathological study
was performed in 27 infected and six uninfected dogs (three infected dogs were not sampled, due to
protocol reasons). Kidneys were evaluated for gross lesions and samples were taken for microscopic
studies. Samples were routinely processed. Briefly, samples were fixed in buffered formalin, embedded
in paraffin, and cut at 4 µm. Two sections per kidney were obtained, and cortical, medullar, and
pelvis areas were examined. Sections were stained by Hematoxylin and Eosin (H-E) and Periodic
Acid-Schiff (PAS).
Glomerular lesions were evaluated in all animals according to the recent consensus of the World
Small Animal Veterinary Association Renal Pathology Initiative [9,10]. Lesions typically associated with
leishmaniasis, such as membranoproliferative glomerulonephritis (MPGN) or mesangioproliferative
glomerulonephritis (PGN) and glomerulosclerosis were assessed. Such lesions were evaluated in
20 random high-power fields (400×) in each kidney. The number of affected glomeruli, as well as the
extension of the lesion within each glomerulus (segmental or diffuse), was used to classify the dogs into
three groups [2]: Group A, dogs with no glomerular alterations; Group B, dogs with <50% of glomeruli
affected; and Group C, dogs with ≥50% of glomeruli affected. Tubular and interstitial lesions were also
considered, and the damage of the tubular epithelium, presence of fibrosis, and characteristics (a type
of inflammatory cells and extension) of the interstitial inflammation were evaluated as previously
described [10], with some modifications. The resulting groups consisted of: Group I, dogs with no
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interstitial inflammation; Group II, dogs with mild, focal, interstitial inflammation; Group III, dogs
with moderate, focal to multifocal, interstitial inflammation; and Group IV, dogs with severe, diffuse,
interstitial inflammation.
2.7. Statistical Analysis
The Shapiro-Wilk test was performed to assess the normality of data. For non-normally-distributed
data, the non-parametric Kruskal-Wallis test was used to determine any statistically significant
differences between groups. Dunn´s post hoc test adjusted by Bonferroni was used for pair-wise
group comparison. Correlations between the parameters studied were determined using Spearman
correlation analysis. Statistical analyses were performed with SPSS v24 (IBM Corporation, Armonk,
NY, USA), and statistical significance was set at α = 0.05.
3. Results
3.1. Clinical Signs and Laboratory Studies
Infected dogs showed clinical signs from ~240 dpi, and 20 were classified as oligosymptomatic
and nine as polysymptomatic. Signs increased throughout the experiment, and ~360 dpi three animals
were classified as oligosymptomatic and 26 as polysymptomatic. Dogs showed doubtful or low
positive antibody levels against Leishmania at ~180 dpi (21 and eight dogs, respectively); however,
at ~240 dpi and onwards throughout the study, all infected animals were seropositive. Regarding
biochemical results (Table 1), only LDH, urea, and sCr were altered. LDH was increased in five
animals from ~240 dpi and onwards and urea in three animals at ~360 dpi. Serum creatinine increased
more than 0.2 mg/dL between ~240 dpi and ~300 dpi in 25 animals. These values remained constant
until the end of the study; however, no azotemia values (sCr > 1.4 mg/dL) were reached in any dog.
Hematological studies revealed no anemia, leukopenia, or thrombocytopenia in any dog throughout
the study. Negative control dogs presented no antibodies, laboratory abnormalities, or clinical signs
compatible with leishmaniasis.
3.2. NGAL Values and Proteinuria Degree
Regard to renal parameters and based on the classification used in this study for UPC and
sCr parameters, Group 1 included three dogs, Group 2 included eight dogs, Group 3 included
18 dogs, and none were classified as Group 4. Statistical analyses showed that uNGAL/C medians
differed significantly among groups (p = 0.004). Post-hoc comparisons showed that this ratio differed
significantly between the control group (median, 0.003; range, 0.002 to 0.018) and Group 3 (median,
0.039; range, 0.006 to 3.043) (p = 0.032), and between the Group 1 (median, 0.003; range, 0.002 to 0.51)
and Group 3 (median, 0.039; range, 0.006 to 3.043) (p = 0.038). In addition, uNGAL/C median values
increased from Group 1 to 3. However, no significant differences were found in sNGAL determinations
between the control group (median, 24.73 mg/dL; range, 7.24 mg/dL to 51 mg/dL), Group 1 (median,
33.22 mg/dL; range, 8.67 mg/dL to 37.96 mg/dL), Group 2 (median, 22.86 mg/dL; range, 10.08 mg/dL to
37.14 mg/dL), and Group 3 (median, 0.39 mg/dL; range, 0.006 mg/dL to 3.043 mg/dL) (p = 0.387), and
there was no increase between Groups 1 to 3 (Figure 1).
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Table 1. Biochemical results at the sampling points. Number and mean ± SD values of animals with
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Value - - - - - - - - -
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* Increase of more than 0.2 mg/dL compared with 240 dpi. No animal reached azotemia values. Reference values:
ALB: 2.3–4.6 gr/dL; ALP: < 212 IU/L; Urea: 20–40 mg/dL; sCr: 0.5–1.2 mg/dL; AST: < 60 IU/L; ALT: < 100 IU/L; LDH:
24–219 IU/L; T-Bil: 0.1–0.6 mg/dL; T-Pro: 5.7–7.5 g/dL.
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The Spearman correlation test did not reveal a statistically significant positive correlation between
sNGAL and sCr (rs = 0.267, p = 0.14), nor between sNGAL and uNGAL (rs = 0.33, p = 0.062). However,
the UPC and uNGAL/C showed a statistically significant positive moderate correlation [39] (rs = 0.482,
p = 0.005) (Figure 2).
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3.3. NGAL Values and Histopathological Study
None of the experimentally infected dogs presented gross lesions in the kidneys; however, 24 (89%)
of them showed microscopic lesions. No histological changes were observed in three (11%) infected
animals or in control dogs.
Glomerulonephritis was observed in 24 infected dogs, including MPGN (11/24 dogs; 46%) and
PGN (13/24 dogs; 54%) (Figure 3). According to the number of affected glomeruli, 13 dogs had less
than 50% of glomeruli injured (Group B), while 11 had more than 50% affected (Group C).
Microorganisms 2020, 8, x FOR PEER REVIEW 7 of 12 
 
3.3. NGAL Values and Histopathological Study 
None of the experimentally infected dogs presented gross lesions in the kidneys; however, 24 
(89%) of them showed microscopic lesions. No histological changes were observed in three (11%) 
infected animals or in control dogs. 
Glomerulonephritis was observed in 24 infected dogs, including MPGN (11/24 dogs; 46%) and 
PGN (13/24 dogs; 54%) (Figure 3). According to the number of affected glomeruli, 13 dogs had less 
than 50% of glomeruli injured (Group B), while 11 had more than 50% affected (Group C). 
 
Figure 3. Representative microphotographs of glomerular lesions in dogs experimentally infected 
with Leishmania infantum (A,B,D,E). (C,F) correspond with control dogs showing normal glomeruli. 
(A–C) are stained with Hematoxylin and Eosin (H-E) and (D–F) with Periodic Acid-Schiff (PAS), and 
all have an original magnification of 400×. (A,D): Mesangioproliferative glomerulonephritis. Note 
groups of three mesangial cells (A), hallmark of this type of glomerulonephritis in dogs and moderate 
increase in mesangial tissue (D). (B,E): Membranoproliferative glomerulonephritis. Note the marked 
increase in basal membranes, best observed with PAS staining (E). A mild increase in cellularity is 
observed in some areas (E). 
UPC and uNGAL/C medians differed significantly among groups (p = 0.004 and p = 0.006, 
respectively. Post-hoc comparisons showed that UPC differed significantly between the control 
group (median, 0.19; range, 0.15 to 0.19) and Group C (median, 0.98; range, 0.25 to 2.96) (p = 0.045). 
Similarly, the uNGAL/C differed significantly between the control group (median, 0.003; range, 0.002 
to 0.018) and Group C (median, 0.54; range, 0.006 to 1.462) (p = 0.043). In terms of the data distribution 
(range values), UPC showed higher variability in each group than uNGAL/C values. In addition, 
uNGAL/C median values increased from Groups A to C, while UPC showed no clear increase 
between Groups B and C. On the other hand, when NGAL was determined in serum, no significant 
differences were found between control group (median, 24.73 mg/dL; range, 7.24 mg/dL to 51 
mg/dL), Group A (median, 33.22 mg/dL; range, 8.67 mg/dL to 37.96 mg/dL), Group B (median, 28.63 
mg/dL; 10.08 mg/dL to 54.06 mg/dL) and Group C (median, 28.18 mg/dL; range, 10.10 mg/dL to 43.9 
mg/dL) (p = 0.96) and increase was not observed between Groups A to C (Figure 4). 
Interstitial lesions were seen in 15 of 27 infected dogs (55%) and were characterized by small foci 
of lymphoplasmacytic interstitial nephritis, mainly located in the corticomedullary junction and renal 
pelvis. All these dogs were included within Group II. According to interstitial inflammation, UPC, 
uNGAL/C, and sNGAL values did not show statistical differences between dogs with interstitial 
Figure 3. Representati i l r i s i s eri enta ly infected
with Leishmania infantu ( , , , . tr l ogs sho ing normal glomeruli.
(A–C) are stained with Hematoxylin and Eosin (H-E) and (D–F) with Periodic Acid-Schiff (PAS), and all
h ve n original magnification of 400×. (A,D): Mesangioprol ferativ glomerulon phritis. Note groups
of three mesangial cells (A), hallmark of this type of glomerulonephritis in dog an moderate increase
in m sangial tissue (D). (B,E): Membranoproliferative glomerulonephritis. Note the marked increase
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Microorganisms 2020, 8, 1966 8 of 12
the uNGAL/C differed significantly between the control group (median, 0.003; range, 0.002 to 0.018) and
Group C (median, 0.54; range, 0.006 to 1.462) (p = 0.043). In terms of the data distribution (range values),
UPC showed higher variability in each group than uNGAL/C values. In addition, uNGAL/C median
values increased from Groups A to C, while UPC showed no clear increase between Groups B and C.
On the other hand, when NGAL was determined in serum, no significant differences were found
between control group (median, 24.73 mg/dL; range, 7.24 mg/dL to 51 mg/dL), Group A (median,
33.22 mg/dL; range, 8.67 mg/dL to 37.96 mg/dL), Group B (median, 28.63 mg/dL; 10.08 mg/dL to
54.06 mg/dL) and Group C (median, 28.18 mg/dL; range, 10.10 mg/dL to 43.9 mg/dL) (p = 0.96) and
increase was not observed between Groups A to C (Figure 4).
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Interstitial lesions were seen in 15 of 27 infected dogs (55%) and were characterized by small
foci of lymphoplasmacytic interstitial nephritis, mainly located in the corticomedullary junction and
renal pelvis. All these dogs were included within Group II. According to interstitial inflammation,
UPC, uNGAL/C, and sNGAL values did not show statistical differences between dogs with interstitial
nephritis and animals without inflammatory changes (Group I) (p = 0.078, p = 0.06, an p = 0.79,
respectively). No tubular lesions were observed in the animals.
4. Discussion
To the author´s knowledge, this is the first study of uNGAL and sNGAL estimations in dogs
experimentally infected with L. infantum. This study has shown that uNGAL/C is higher in non-azotemic
Leishmania-infected dogs with proteinuria compared with non-proteinuric dogs. This finding suggests
that uNGAL may detect mild glomerular lesions with proteinuria. Interestingly, uNGAL has also
been considered a good marker of renal recovery during specific treatments in humans with low-level
proteinuria [40]. Similar studies in canine leishmaniasis would be beneficial. However, uNGAL does
not seem to predict deaths in azotemic dogs when CKD is clinically evident or azotemic AKI dogs,
in contrast with sCr [27,41]. In our study no azotemic dogs were found, avoiding estimations of
these parameters.
A major limitation of NGAL studies is the difficulty to determine whether uNGAL increases
exclusively in response to kidney damage, or it is due to other conditions [29]: Increasing glomerular
NGAL filtration in otherwise normal glomeruli might occur in systemic conditions, such as
immunological, metabolic, and inflammatory diseases, due to an increased sNGAL [24,37]. In this
study, NGAL was also determined in serum to rule out the role of systemic diseases. An important
advantage of our experimental protocol is that it allowed us to exclude most of these diseases.
No significant increase of sNGAL compared with the control group was detected, suggesting that the
increase in uNGAL was of renal origin and not from systemic inflammation. Although evaluation of
inflammatory markers would have been needed to assess the systemic inflammation status, a mild
systemic inflammation was observed after the histopathological study of all organs in all infected dogs
(these data are not shown because they are part of other study). Thus, we consider that, under our
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experimental conditions, Leishmania was able to induce mild inflammation; however, this degree of
inflammation is not enough to induce an increase in sNGAL. Further studies, however, are needed in
natural cases and dogs with different degrees of systemic inflammation, due to Leishmania infection to
estimate possible variations of NGAL in serum.
In addition to increasing glomerular filtration, deficiency of tubular reabsorption and tubular
production can also influence uNGAL concentration [40]. Urinary NGAL has been associated with
tubular or tubulointerstitial injuries [9,10,28]. Furthermore, when tubulointerstitial lesions are severe
as in end-stage kidneys, uNGAL may also be increased as a result of glomerular proteinuria [10].
Our study revealed that after one year of the infection with L. infantum, renal lesions were predominantly
glomerular with insignificant tubulointerstitial changes. Therefore, it can be speculated that uNGAL
mainly reflects glomerular damage in the absence of tubular injuries. Both UPC and uNGAL/C
significantly increased in animals, with more than 50% of glomeruli affected (Group C). However,
UPC values were broadly dispersed compared with uNGAL/C, suggesting that uNGAL is a more
robust biomarker.
In contrast, although no significant tubulointerstitial lesions were observed in the present study,
and uNGAL was suspected to be associated with glomerular lesions, tubular participation cannot
be discarded. Besides to tubular degeneration, insufficient tubular reabsorption may also be due to
saturation of its absorptive capacity. Albumin is a protein with low molecular weight and is considered
to be the first protein detected in cases of proteinuria [42]. Because NGAL is smaller than albumin, they
are expected to be filtrated together. As both are reabsorbed by the same receptors [40], competition
might occur. This situation is expected in low-level proteinuria and may occur in the early stages of
kidney disease; however, in these cases, creatinine has not been clearly shown to increase, so uNGAL
estimation could detect earlier kidney changes.
On the other hand, NGAL production by tubular cells as a protective function has also been
demonstrated [40], and this situation is thought to occur in mild renal injuries. Reabsorption for
saturation and greater production in early renal pathology might explain the greater sensitivity of the
uNGAL/C when compared to UPC in detecting mild renal lesions. This possible explanation would be
in accordance with the Forest Fire theory. In this analogy, nephrons represent the trees in the forest, and
NGAL represents the fire. After damage, the remaining nephrons re-establish renal function, which is
commonly evaluated as the sCr concentration. In this model, NGAL indicates the active lesions during
renal damage [43]. This theory aligns well with our histological findings, in which no tubulointerstitial
lesions were detected, and only glomerular lesions were seen. In this situation, tubular cells were able
to produce NGAL, in contrast with tubular cells seen in chronic-end-stage kidneys where interstitial
lesions predominate. This condition typically occurs in natural cases of canine leishmaniasis when the
disease is diagnosed and presents a very poor prognosis [2].
Renal lesions in dogs infected by L. infantum are characterized by glomerular and tubulointerstitial
changes [2]. Proteinuria, due to glomerular lesions and tubular saturation, has been suggested as
a contributing factor in the development of tubulointerstitial injuries [21]. In this study, significant
lesions were observed only in the glomeruli, whereas interstitial lesions, characterized by focal mild
mononuclear interstitial nephritis, were insignificant. Moreover, interstitial lesions were not seen in
all dogs with glomerular lesions. The post-infection time at which dogs were euthanized probably
explained the lack of significant tubulointerstitial lesions. Nevertheless, statistical analyses comparing
interstitial lesions and uNGAL/C values were performed, and no significant differences were detected
(p = 0.06).
In our study, over 11% of the infected dogs showed no renal pathology. Glomerular lesions in
canine leishmaniasis are characterized by the presence of MPGN, PGN, or glomerulosclerosis and are
typically associated with immune-complex deposition [2]. In our study, no lesions of glomerulosclerosis
were observed, suggesting that these chronic lesions are not yet developed after one year of infection.
Both types of glomerulonephritis were seen, although PGN predominated over MPGN (54% and 46%,
respectively). These percentages are similar to those reported by other authors [44]. The study confirms
Microorganisms 2020, 8, 1966 10 of 12
that L. infantum induces renal disease in dogs, in which glomerular damage is initially observed and
that the response to infection varies between dogs, even within the same breed.
This work is an experimental study and has some limitations. The two main limitations have
been the lack of azotemic dogs and the lack of some previous uNGAL determinations throughout the
experiment. These data might have provided more relevant information about the potential value
of this renal biomarker. Further studies are needed to verify these findings in natural infections by
L. infantum. Another limitation of this experimental study was that UTI was not ruled out. Urinary tract
infections and noninfectious pyuria have been suggested to influence uNGAL values [45,46]. Although
no signs suggesting UTI were observed in our study such as pathological findings in the sediment
(hematuria, pyuria), clinical signs (stranguria, pollakiuria, dysuria), urine culture would have been the
only method to rule out the presence certain pathogens that can provoke asymptomatic infections.
5. Conclusions
This study demonstrates that uNGAL is increased in proteinuric and non-azotemic dogs, and that
correlates with the presence of glomerular lesions in dogs experimentally infected with L. infantum.
These results also suggest that sNGAL may not be a sensitive indicator of the levels of proteinuria.
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